Safety profile of mycophenolate mofetil
- 1 December 2000
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 26 (12) , 1362-1363
- https://doi.org/10.1038/sj.bmt.1702723
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantationBone Marrow Transplantation, 2000
- Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA‐mismatched bone marrow transplant patientsClinical Transplantation, 2000
- Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimusBone Marrow Transplantation, 1999
- ADVERSE EFFECTS OF MYCOPHENOLATE MOFETIL IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS WITH PRESUMED CHRONIC REJECTIONTransplantation, 1999
- MYCOPHENOLATE MOFETIL AND CYCLOSPORINE AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS AFTER ALLOGENEIC BLOOD STEM CELL TRANSPLANTATIONTransplantation, 1999
- Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipientTransplantation Proceedings, 1998
- Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients.Bone Marrow Transplantation, 1998
- A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1996
- MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1995